AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
149,26 €
-4,16 %
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $189.00 to $193.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $160.00.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $193.00 to $196.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Raymond James from $177.00 to $181.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $170.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $175.00 to $185.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Raymond James from $181.00 to $189.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at BMO Capital Markets from $187.00 to $195.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Truist Financial Co. from $180.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Guggenheim from $188.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $185.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
StockNews_com in TechnipFMC PLC diskutieren